
 
 
 
 
 
 
 
 
   
 1. the palliative of the excess moisture secretion in an intestinal tube, pressure diarrhoea, pressure bowel disturbance, irritable bowel syndrome or inflammatory bowel, it is characterized in that, containing Lactobacillus gasseri CP2305s strain (NITE BP-1405) or by Lactobacillus gasseri CP2305 strain (FERM BP-11331) or the derivative derivative strain of CP2305s strain (NITE BP-1405), their bacterial disposing thing or their mixture as effective ingredient. 
 
     
 2. the excess moisture secretion in intestinal tube or a palliative for pressure diarrhoea, is characterized in that, containing Lactobacillus gasseri CP2305 strain (FERM BP-11331), its bacterial disposing thing or their mixture as effective ingredient. 
 
     
 3. the excess moisture in an intestinal tube is secreted, pressure is suffered from diarrhoea or the palliative of pressure bowel disturbance, it is characterized in that, the sterilization body containing Lactobacillus gasseri CP2305 strain (FERM BP-11331), its bacterial disposing thing or their mixture are as effective ingredient. 
 
     
 
   
   
 
 4. palliative according to claim 1 and 2, wherein, described CP2305 strain, described CP2305s strain or be viable bacteria body or sterilization body by Lactobacillus gasseri CP2305 strain (FERM BP-11331) or the derivative derivative strain of CP2305s strain (NITEBP-1405). 
 
     
 
   
   
   
   
 
 5. the palliative according to any one of Claims 1 to 4, wherein, described bacterial disposing thing is dry thalline, destroys thalline, broken thalline or fermentation milk. 
 
     
 
   
   
   
   
   
 
 6. the palliative according to any one of Claims 1 to 5, it has the effect hindering pelvis (parasympathetic) the neururgic suppression caused by pressure. 
 
     
 
   
   
   
   
   
   
 
 7. the palliative according to any one of claim 1 ~ 6, it has the effect suppressing moisture to be secreted by suppressing large intestine chloride channel. 
 
     
 
   
   
   
   
   
   
   
 
 8. the palliative according to any one of claim 1 ~ 7, it is the improving agent of pressure diarrhoea. 
 
     
 9. a manufacture method for animal feed, it comprise by the palliative described in any one of claim 1 ~ 8 and animal feed ingredient compounding and manufacture the operation of animal feed. 
 
     
 10. an animal feed, it contains Lactobacillus gasseri CP2305s strain (NITE BP-1405) or by the viable bacteria body of Lactobacillus gasseri CP2305 strain (FERM BP-11331) or the derivative derivative strain of CP2305s strain (NITE BP-1405) or sterilization body, their bacterial disposing thing or their mixture. 
 
     
 11. 1 kinds of food additive or animal feed additive, it contains the palliative described in any one of claim 1 ~ 10. 
 
     
 12. 1 kinds of food additives, it contains Lactobacillus gasseri CP2305 strain (FERM BP-11331), Lactobacillus gasseri CP2305s strain (NITE BP-1405) or the viable bacteria body of derivative strain derived by Lactobacillus gasseri CP2305 strain (FERMBP-11331) or CP2305s strain or sterilization body, their bacterial disposing thing or their mixture. 
 
     
 13. 1 kinds of diet product, it contains Lactobacillus gasseri CP2305s strain (NITE BP-1405) or the viable bacteria body of derivative strain that derived by Lactobacillus gasseri CP2305 strain (FERM BP-11331) or CP2305s strain or sterilization body, their bacterial disposing thing or their mixture. 
 
     
 
   
 
 14. diet product according to claim 13, it is functional diet product. 
 
     
 The manufacture method of 15. 1 kinds of functional diet product, it comprises: by the carrier of the palliative described in any one of claim 1 ~ 8 and food, excipient or mixing diluents, according to circumstances mixed food additive further, thus manufacturing function diet product. 
 
     
 16. 1 kinds of pharmaceutical compositions, it is for preventing, alleviating or suppress or treat excess moisture secretion in intestinal tube, pressure diarrhoea, pressure bowel disturbance, irritable bowel syndrome or inflammatory bowel, it is characterized in that, containing Lactobacillus gasseri CP2305s strain (NITE BP-1405) or the viable bacteria body of derivative strain derived by Lactobacillus gasseri CP2305 strain (FERM BP-11331) or CP2305s strain or sterilization body, their bacterial disposing thing or their mixture as effective ingredient. 
 
     
 17. 1 kinds of pharmaceutical compositions, its for prevent, alleviate or suppress or treat in intestinal tube excess moisture secretion or pressure diarrhoea, it is characterized in that, containing Lactobacillus gasseri CP2305 strain (FERMBP-11331), its bacterial disposing thing or their mixture as effective ingredient. 
 
     
 18. 1 kinds of pharmaceutical compositions, its for prevent, alleviate or suppress or treat in intestinal tube excess moisture secretion, pressure diarrhoea, pressure bowel disturbance, it is characterized in that, the sterilization body containing Lactobacillus gasseri CP2305 strain (FERM BP-11331), its bacterial disposing thing or their mixture are as effective ingredient. 
 
     
 19. 1 kinds of pharmaceutical compositions, it is for preventing, alleviating or suppress or treat excess moisture secretion in intestinal tube, pressure diarrhoea, pressure bowel disturbance, irritable bowel syndrome or inflammatory bowel, it comprises the palliative described in any one of claim 1 ~ 8, and carrier, excipient or the diluent that pharmaceutically can allow. 
 
     
 20. 1 kinds of lactobacilluss, what it had with Lactobacillus gasseri CP2305 strain (FERM BP-11331) or Lactobacillus gasseri CP2305s strain (NITE BP-1405) equal above pressure bowel disturbance alleviates effect, and different from CP2305 strain. 
 
     
 
   
 
 21. lactobacilluss according to claim 20, wherein, described pressure bowel disturbance alleviate the diarrhoea scoring meter done in order to described in the embodiment 3 of description, there is the equal above pressure with Lactobacillus gasseri CP2305 strain (FERM BP-11331) or Lactobacillus gasseri CP2305s strain (NITE BP-1405) and to suffer from diarrhoea inhibitory action. 
 
     
 22. 1 kinds of lactobacilluss, when diarrhoea scoring being evaluated by the method described in the embodiment 3 of description, compare with placebo, (compare p<0.05 from placebo) significantly and suppress pressure and to suffer from diarrhoea and different with CP2305 strain (FERM BP-11331). 
 
     
 
   
   
   
 
 23. lactobacilluss according to any one of claim 20 ~ 22, it has and keeps 5 little survival rates to be constantly the Heat pretreatment of more than 60% on ice. 
 
     
 
   
   
   
   
 
 24. lactobacilluss according to any one of claim 20 ~ 23, it has the effect hindering pelvis (parasympathetic) the neururgic suppression caused by pressure. 
 
     
 
   
   
   
   
   
   
 
 25. lactobacilluss according to any one of claim 19 ~ 24, it has the effect suppressing moisture to be secreted by suppressing large intestine chloride channel. 
 
     
 
   
   
   
   
   
   
 
 26. lactobacilluss according to any one of claim 20 ~ 25, it is characterized in that, described lactobacillus is the lactobacillus belonging to Lactobacillus gasseri kind. 
 
     
 
   
   
   
   
   
   
   
 
 27. lactobacilluss according to any one of claim 20 ~ 26, wherein, described lactobacillus is Lactobacillus gasseri CP2305s strain (NITE BP-1405), the derivative strain of Lactobacillus gasseri CP2305 strain (FERMBP-11331) or the derivative strain of Lactobacillus gasseri CP2305s strain (NITE BP-1405). 
 
     
 
   
   
   
   
   
   
   
   
 
 28. lactobacilluss according to any one of claim 20 ~ 27, it is for preventing or alleviating excess moisture secretion in intestinal tube, pressure diarrhoea, pressure bowel disturbance, irritable bowel syndrome, diarrhea type irritable bowel syndrome or inflammatory bowel. 
 
     
 The manufacture method of 29. 1 kinds of lactobacillus Heat pretreatment strain, it comprises: temperature lactobacillus being exposed to less than 10 DEG C, selects the Heat pretreatment strain of existence, carries out breeding, repeatedly this operation, and reclaims the Heat pretreatment strain of existence. 
 
     
 
   
 
 30. methods according to claim 29, wherein, lactobacillus is the lactobacillus or the Lactobacillus gasseri CP2305 strain (FERM BP-11331) that belong to Lactobacillus gasseri kind. 
 
     
 31. 1 kinds of lactobacilluss, its derivative strain comprising Lactobacillus gasseri CP2305s strain (NITE BP-1405) or derived by Lactobacillus gasseri CP2305 strain (FERM BP-11331) or CP2305s strain. 
 
     
 32. 1 kinds of lactobacilluss, it has and keeps 5 little survival rates to be constantly the Heat pretreatment of more than 60% on ice. 
 
     
 
   
 
 33. lactobacilluss according to claim 32, is characterized in that, described lactobacillus is the lactobacillus belonging to Lactobacillus gasseri kind. 
 
     
 The prevention of the excess moisture secretion in 34. 1 kinds of intestinal tubes, pressure diarrhoea, pressure bowel disturbance, irritable bowel syndrome, diarrhea type irritable bowel syndrome or inflammatory bowel or palliative, it is characterized in that, containing claim 20 ~ 27 and 31 ~ 33 any one described in lactobacillus as effective ingredient. 
 
   
 
 
 
 
 
 
 
 
